We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » China’s SFDA Requests Recall of GSK Antibiotic Augmentin
China’s SFDA Requests Recall of GSK Antibiotic Augmentin
July 8, 2011
China’s State Food and Drug Administration (SFDA) has ordered a recall of GlaxoSmithKline’s (GSK) antibiotic Augmentin after tests showed the product contained traces of a plastics additive. Drug GMP Report
